Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 11 |
GO:0005814 | centriole | 5 | 11 |
GO:0005874 | microtubule | 6 | 11 |
GO:0005929 | cilium | 4 | 11 |
GO:0042995 | cell projection | 2 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0043228 | non-membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 11 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 11 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 11 |
GO:0099080 | supramolecular complex | 2 | 11 |
GO:0099081 | supramolecular polymer | 3 | 11 |
GO:0099512 | supramolecular fiber | 4 | 11 |
GO:0099513 | polymeric cytoskeletal fiber | 5 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9AIA4
Term | Name | Level | Count |
---|---|---|---|
GO:0007017 | microtubule-based process | 2 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0030030 | cell projection organization | 4 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0000226 | microtubule cytoskeleton organization | 3 | 1 |
GO:0000278 | mitotic cell cycle | 3 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0007010 | cytoskeleton organization | 5 | 1 |
GO:0007049 | cell cycle | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0005198 | structural molecule activity | 1 | 11 |
GO:0005200 | structural constituent of cytoskeleton | 2 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0005525 | GTP binding | 5 | 11 |
GO:0017076 | purine nucleotide binding | 4 | 11 |
GO:0019001 | guanyl nucleotide binding | 5 | 11 |
GO:0032553 | ribonucleotide binding | 3 | 11 |
GO:0032555 | purine ribonucleotide binding | 4 | 11 |
GO:0032561 | guanyl ribonucleotide binding | 5 | 11 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0097367 | carbohydrate derivative binding | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.295 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.630 |
CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.542 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.297 |
CLV_PCSK_KEX2_1 | 439 | 441 | PF00082 | 0.433 |
CLV_PCSK_PC1ET2_1 | 439 | 441 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 286 | 290 | PF00082 | 0.566 |
CLV_PCSK_SKI1_1 | 334 | 338 | PF00082 | 0.542 |
CLV_PCSK_SKI1_1 | 355 | 359 | PF00082 | 0.581 |
CLV_PCSK_SKI1_1 | 383 | 387 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.289 |
DEG_APCC_DBOX_1 | 354 | 362 | PF00400 | 0.322 |
DOC_MAPK_gen_1 | 219 | 229 | PF00069 | 0.475 |
DOC_MAPK_HePTP_8 | 175 | 187 | PF00069 | 0.561 |
DOC_MAPK_HePTP_8 | 217 | 229 | PF00069 | 0.358 |
DOC_MAPK_MEF2A_6 | 178 | 187 | PF00069 | 0.561 |
DOC_MAPK_MEF2A_6 | 220 | 229 | PF00069 | 0.472 |
DOC_PP1_RVXF_1 | 182 | 188 | PF00149 | 0.539 |
DOC_PP1_RVXF_1 | 284 | 291 | PF00149 | 0.575 |
DOC_PP2B_LxvP_1 | 300 | 303 | PF13499 | 0.410 |
DOC_PP2B_LxvP_1 | 339 | 342 | PF13499 | 0.577 |
DOC_PP4_FxxP_1 | 187 | 190 | PF00568 | 0.472 |
DOC_USP7_MATH_1 | 272 | 276 | PF00917 | 0.683 |
DOC_USP7_MATH_1 | 293 | 297 | PF00917 | 0.426 |
DOC_USP7_MATH_1 | 342 | 346 | PF00917 | 0.612 |
DOC_USP7_MATH_1 | 406 | 410 | PF00917 | 0.640 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.545 |
LIG_14-3-3_CanoR_1 | 184 | 190 | PF00244 | 0.567 |
LIG_14-3-3_CanoR_1 | 286 | 291 | PF00244 | 0.565 |
LIG_14-3-3_CanoR_1 | 344 | 350 | PF00244 | 0.538 |
LIG_14-3-3_CanoR_1 | 408 | 413 | PF00244 | 0.545 |
LIG_14-3-3_CanoR_1 | 414 | 424 | PF00244 | 0.464 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.311 |
LIG_BRCT_BRCA1_1 | 154 | 158 | PF00533 | 0.561 |
LIG_BRCT_BRCA1_1 | 45 | 49 | PF00533 | 0.472 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.499 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.471 |
LIG_FHA_1 | 245 | 251 | PF00498 | 0.464 |
LIG_FHA_1 | 283 | 289 | PF00498 | 0.575 |
LIG_FHA_1 | 313 | 319 | PF00498 | 0.506 |
LIG_FHA_1 | 372 | 378 | PF00498 | 0.510 |
LIG_FHA_1 | 426 | 432 | PF00498 | 0.625 |
LIG_FHA_2 | 287 | 293 | PF00498 | 0.421 |
LIG_GBD_Chelix_1 | 175 | 183 | PF00786 | 0.361 |
LIG_LIR_Gen_1 | 155 | 164 | PF02991 | 0.469 |
LIG_LIR_Gen_1 | 17 | 25 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 345 | 353 | PF02991 | 0.577 |
LIG_LIR_Nem_3 | 155 | 161 | PF02991 | 0.469 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.472 |
LIG_MAD2 | 334 | 342 | PF02301 | 0.571 |
LIG_MLH1_MIPbox_1 | 45 | 49 | PF16413 | 0.472 |
LIG_NRBOX | 296 | 302 | PF00104 | 0.492 |
LIG_PCNA_yPIPBox_3 | 291 | 301 | PF02747 | 0.480 |
LIG_Pex14_1 | 94 | 98 | PF04695 | 0.459 |
LIG_PTB_Apo_2 | 204 | 211 | PF02174 | 0.358 |
LIG_SH2_STAP1 | 200 | 204 | PF00017 | 0.561 |
LIG_SH2_STAT3 | 215 | 218 | PF00017 | 0.358 |
LIG_SH2_STAT3 | 435 | 438 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 326 | 329 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 371 | 374 | PF00017 | 0.608 |
LIG_SH2_STAT5 | 426 | 429 | PF00017 | 0.588 |
LIG_SH2_STAT5 | 435 | 438 | PF00017 | 0.505 |
LIG_SH3_3 | 266 | 272 | PF00018 | 0.641 |
LIG_SH3_3 | 370 | 376 | PF00018 | 0.518 |
LIG_SH3_3 | 427 | 433 | PF00018 | 0.503 |
LIG_SUMO_SIM_anti_2 | 159 | 166 | PF11976 | 0.472 |
LIG_SUMO_SIM_anti_2 | 256 | 262 | PF11976 | 0.489 |
LIG_SUMO_SIM_anti_2 | 295 | 302 | PF11976 | 0.210 |
LIG_SUMO_SIM_par_1 | 159 | 166 | PF11976 | 0.472 |
LIG_TRAF2_2 | 192 | 197 | PF00917 | 0.561 |
LIG_TYR_ITIM | 96 | 101 | PF00017 | 0.472 |
LIG_UBA3_1 | 357 | 362 | PF00899 | 0.604 |
LIG_WW_1 | 323 | 326 | PF00397 | 0.586 |
MOD_CK1_1 | 177 | 183 | PF00069 | 0.534 |
MOD_CK1_1 | 273 | 279 | PF00069 | 0.643 |
MOD_CK1_1 | 282 | 288 | PF00069 | 0.559 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.511 |
MOD_CK1_1 | 345 | 351 | PF00069 | 0.535 |
MOD_CK1_1 | 400 | 406 | PF00069 | 0.691 |
MOD_CK2_1 | 146 | 152 | PF00069 | 0.593 |
MOD_CK2_1 | 286 | 292 | PF00069 | 0.438 |
MOD_GlcNHglycan | 152 | 157 | PF01048 | 0.410 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.159 |
MOD_GlcNHglycan | 271 | 275 | PF01048 | 0.629 |
MOD_GlcNHglycan | 278 | 281 | PF01048 | 0.623 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.302 |
MOD_GlcNHglycan | 388 | 391 | PF01048 | 0.542 |
MOD_GlcNHglycan | 392 | 395 | PF01048 | 0.587 |
MOD_GlcNHglycan | 408 | 411 | PF01048 | 0.458 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.254 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.538 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.472 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.493 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.595 |
MOD_GSK3_1 | 282 | 289 | PF00069 | 0.542 |
MOD_GSK3_1 | 322 | 329 | PF00069 | 0.534 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.412 |
MOD_GSK3_1 | 386 | 393 | PF00069 | 0.694 |
MOD_GSK3_1 | 400 | 407 | PF00069 | 0.590 |
MOD_GSK3_1 | 434 | 441 | PF00069 | 0.685 |
MOD_N-GLC_1 | 225 | 230 | PF02516 | 0.329 |
MOD_N-GLC_1 | 242 | 247 | PF02516 | 0.157 |
MOD_N-GLC_1 | 293 | 298 | PF02516 | 0.205 |
MOD_N-GLC_1 | 43 | 48 | PF02516 | 0.289 |
MOD_NEK2_1 | 242 | 247 | PF00069 | 0.535 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.516 |
MOD_NEK2_1 | 327 | 332 | PF00069 | 0.486 |
MOD_NEK2_1 | 381 | 386 | PF00069 | 0.555 |
MOD_NEK2_1 | 415 | 420 | PF00069 | 0.591 |
MOD_NEK2_2 | 392 | 397 | PF00069 | 0.441 |
MOD_PIKK_1 | 18 | 24 | PF00454 | 0.572 |
MOD_PIKK_1 | 236 | 242 | PF00454 | 0.459 |
MOD_PIKK_1 | 434 | 440 | PF00454 | 0.433 |
MOD_PKA_1 | 146 | 152 | PF00069 | 0.557 |
MOD_PKA_1 | 416 | 422 | PF00069 | 0.464 |
MOD_PKA_2 | 142 | 148 | PF00069 | 0.452 |
MOD_PKA_2 | 422 | 428 | PF00069 | 0.465 |
MOD_Plk_1 | 225 | 231 | PF00069 | 0.471 |
MOD_Plk_1 | 242 | 248 | PF00069 | 0.450 |
MOD_Plk_1 | 293 | 299 | PF00069 | 0.381 |
MOD_Plk_4 | 163 | 169 | PF00069 | 0.484 |
MOD_Plk_4 | 279 | 285 | PF00069 | 0.617 |
MOD_Plk_4 | 293 | 299 | PF00069 | 0.242 |
MOD_Plk_4 | 322 | 328 | PF00069 | 0.475 |
MOD_Plk_4 | 334 | 340 | PF00069 | 0.425 |
MOD_Plk_4 | 422 | 428 | PF00069 | 0.742 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.545 |
MOD_SUMO_for_1 | 101 | 104 | PF00179 | 0.561 |
MOD_SUMO_rev_2 | 46 | 55 | PF00179 | 0.532 |
MOD_SUMO_rev_2 | 61 | 67 | PF00179 | 0.371 |
TRG_ENDOCYTIC_2 | 346 | 349 | PF00928 | 0.478 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.472 |
TRG_ER_diArg_1 | 182 | 185 | PF00400 | 0.561 |
TRG_ER_diArg_1 | 219 | 222 | PF00400 | 0.552 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NWW5 | Trypanosomatidae | 46% | 86% |
A0A3S5H784 | Leishmania donovani | 85% | 73% |
A0A422NCE3 | Trypanosoma rangeli | 51% | 92% |
A4HYR4 | Leishmania infantum | 85% | 73% |
C9ZI66 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 92% |
D0A8V4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 91% |
E9AUJ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 73% |
P25295 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 25% | 100% |
P32348 | Microbotryum violaceum | 25% | 95% |
P34786 | Euplotoides octocarinatus | 26% | 96% |
P53377 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 24% | 96% |
P54402 | Euplotes aediculatus | 25% | 96% |
P90548 | Euplotoides octocarinatus | 26% | 96% |
Q4QCZ3 | Leishmania major | 85% | 73% |
Q4R7T7 | Macaca fascicularis | 25% | 98% |
Q75A43 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 23% | 94% |
Q7Z9Z2 | Coprinopsis cinerea (strain Okayama-7 / 130 / ATCC MYA-4618 / FGSC 9003) | 26% | 98% |
Q8HZV4 | Canis lupus familiaris | 26% | 98% |
Q9R1K7 | Mus musculus | 26% | 98% |
Q9UJT1 | Homo sapiens | 26% | 98% |
Q9Y882 | Schizosaccharomyces japonicus | 24% | 100% |
V5BAC4 | Trypanosoma cruzi | 51% | 92% |